Analyst picks & changes

Sequus Pharmaceuticals Inc.

(SEQU), Menlo Park, Calif.

Business: Cancer

Hanifen, Imhoff analyst Robert Swift rated SEQ "underperform" based on his

Read the full 200 word article

How to gain access

Continue reading with a
two-week free trial.